organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 91³Ô¹Ï Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
91³Ô¹Ï Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Journal of Infectious Diseases & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Infectious Diseases & Therapy has got h-index 18, which means every article in Journal of Infectious Diseases & Therapy has got 18 average citations.
Following are the list of articles that have cited the articles published in Journal of Infectious Diseases & Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 80 | 75 | 72 | 102 | 30 | 40 | 39 | 51 |
Research, Review articles and Editorials |
45 | 85 | 71 | 65 | 45 | 302 | 40 | 39 | 8 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
0 | 3 | 3 | 7 | 3 | 2 | 0 | 0 | 0 |
Conference proceedings |
0 | 33 | 49 | 0 | 0 | 54 | 250 | 213 | 231 |
Citations received as per Google Scholar, other indexing platforms and portals |
148 | 255 | 248 | 285 | 312 | 302 | 284 | 303 | 25 |
Journal total citations count | 1529 |
Journal impact factor | 2.47 |
Journal 5 years impact factor | 3.00 |
Journal cite score | 2.81 |
Journal h-index | 18 |
Journal h-index since 2019 | 14 |
![]() |
Mechanisms of antimicrobial resistance (AMR) and alternative approaches to overcome AMR |
| | | |
![]() |
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. |
| | | |
![]() |
Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria. |
| | | |
![]() |
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter. |
| | | |
![]() |
Brief Note on Gene Technology and Genetic Engineering |
| | | |
![]() |
HIV/AIDS: A Brief Overview |
View at Publisher | | | |
![]() |
Human MicroRNA-602 Inhibits Hepatitis C Virus Genotype 1b Infection and Promotes Tumor Suppressor Gene Expression in a Hepatoma Cell Line |
| | | |
![]() |
Circulatory miR-221 & miR-542 expression profiles as potential molecular biomarkers in Hepatitis C Virus mediated liver cirrhosis and hepatocellular carcinoma. |
| | | |
![]() |
The burden of hepatitis c virus infection and access to treatment among rural dwellers in a north central Nigeria |
| | | |
![]() |
Prevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, Rwanda |
| | | |
![]() |
Low prevalence of hepatitis C virus RNA in blood donors with anti-hepatitis C virus reactivity in Rwanda. |
| | | |
![]() |
Prevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, Rwanda |
| | | |
![]() |
Controlling hepatitis C in Rwanda: a framework for a national response. |
| | | |
![]() |
Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda |
| | | |
![]() |
Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach. |
| | | |
![]() |
Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach. |
| | | |
![]() |
Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study. |
| | | |
![]() |
Short Review on Permethrin |
| | | |
![]() |
Predicting Infections Using Computational Intelligence – A Systematic Review |
| | | |
![]() |
Cellular Breathing and its Kinds |
| | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, 91³Ô¹Ï Journals